Health News - Health Magazine - Health Company Reports

Advertise | About Us | Contact Us | Press Releases | Testimonials

Market Sectors: Pharmaceuticals

Featured Articles

Sun: Settles on Taro with Israeli SC verdict

Sun: Settles on Taro with Israeli SC verdict

BY: n.namazi | Thu Sep 9, 2010

TAGS: Healthcare

The Israeli SC rejected an appeal by Taro Pharmaceutical to block Sun Pharmaceutical from raising its stake in the company.

Vertex: Hepatitis C drug can help patients

Vertex: Hepatitis C drug can help patients

Avandia: To be pulled out from market

Avandia: To be pulled out from market

Sun Pharma: Gets FDA approval for new drug

Sun Pharma: Gets FDA approval for new drug

	Comment
	Sun: Settles on Taro with Israeli SC verdict BY: n.namazi \| Thu Sep 9, 2010 TAGS: Pharmaceuticals, Sarabjit Kour, Sun Pharmaceutical, Taro Pharmaceutical The Israeli SC rejected an appeal by Taro Pharmaceutical to block Sun Pharmaceutical from raising its stake in the company.

	Comment
	Vertex: Hepatitis C drug can help patients BY: n.namazi \| Wed Sep 8, 2010 TAGS: boceprevir, Hepatitis C drug, telaprevir, Vertex Pharmaceuticals Inc Vertex Pharmaceuticals Inc. has said that its Hepatitis C drug ‘telaprevir’ can greatly benefit patients.

	Comment
	Avandia: To be pulled out from market BY: n.namazi \| Tue Sep 7, 2010 TAGS: Avandia, British Medical Journal, GlaxoSmithKline, GSK, rosiglitazone British Medical Journal wants Avandia to be withdrawn from the market.

	Comment
	Sun Pharma: Gets FDA approval for new drug BY: n.namazi \| Fri Sep 3, 2010 TAGS: Bombay Stock Exchange, FDA, food and drug administration, Pharmaceuticals, Sun Pharma Sun Pharma said it has received FDA approval for their hyperactivity disorder drug.

	Comment
	Sun Pharma: Gets FDA approval for new drug BY: n.namazi \| Fri Sep 3, 2010 TAGS: Bombay Stock Exchange, FDA, food and drug administration, Pharmaceuticals, Sun Pharma Sun Pharma said it has received FDA approval for their hyperactivity disorder drug.

	Comment
	Shasun: Enters into a JV with Nanoparticle Biochem BY: n.namazi \| Tue Aug 31, 2010 TAGS: Nanoparticle Biochem Inc, pharmaceutical, SCDL, Shasun Chemicals and Drugs Limited, Shasun Pharmaceuticals Chennai based Shasun Pharmaceuticals Ltd. has entered into a joint venture with U.S. based Nanoparticle Biochem Inc.

	Comment
	Haw Par Corporation Ltd : Competence with the Counter Product BY: s.dutta \| Wed Aug 11, 2010 TAGS: FDA, Haw Par Corporation Ltd, Haw Par Healthcare Ltd, Kwan Loong, Tiger Balm, U.S. Food and Drug Administration Singapore based Haw Par Corporation Ltd, the maker of Tiger Balm, failed to adequately test its healthcare unit's over-the-counter products, the U.S. drug regulator said.

	Comment
	Glenmark and Sepracor: Into the License Agreement BY: s.dutta \| Tue Aug 10, 2010 TAGS: Eszopiclone, Glenmark, Glenmark Generics, Glenmark Pharmaceuticals, Lunesta, Sepracor, USA Sepracor has entered into a settlement and licence agreement with Glenmark Generics, USA, Glenmark Generics and Glenmark Pharmaceuticals.

	Comment
	Jazz Pharmaceuticals Inc: Fall in shares BY: n.namazi \| Tue Aug 24, 2010 TAGS: FDA drug reviews, FDA panel, Jazz Pharmaceuticals Inc Shares of Jazz Pharmaceuticals Inc. fall after a negative panel vote by FDA experts.

	Comment
	Aspen Pharmacare buys Herron Pharmaceuticals BY: n.namazi \| Tue Aug 17, 2010 TAGS: Aspen Pharmacare Holdings Ltd, Herron Pharmaceuticals, Pharmaceuticals company, Sigma Pharmaceuticals Ltd South Africa-based Aspen Pharmacare is set to acquire the Herron range as part of a $900 million deal.